The low-dose group recorded an average 81.7% reduction in liver fat, while the high-dose group saw an 86% decline
Reported appetite, taste and smell changes following Roux-en-Y gastric bypass and sleeve gastrectomy: effect of gender, type 2 diabetes and relationship to post-operative weight loss
Previous early studies suggest GLP-1s may be linked to a lower risk of certain cancers, cardiovascular disease, addiction, and even migraine severity
With the growing popularity of GLP-1 medications, many women are asking an important question: Can I take these medications if Im trying to get pregnant? As a fertility nutritionist, this is one of the most common questions I receive from women who are struggling with weight, PCOS, or insulin resistance while planning for pregnancy
The demand for these treatments often comes from those who want both cosmetic and health-related improvements